BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1136 related articles for article (PubMed ID: 25780303)

  • 21. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session].
    El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC
    Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Staging of hepatocellular carcinoma. Comparison of ultrasonography, computerized tomography, magnetic resonance, digital angiography, and computerized tomography with lipiodol].
    Bartolozzi C; Lencioni R; Caramella D; Gibilisco G; Cioni R; Vignali C
    Radiol Med; 1994 Oct; 88(4):429-36. PubMed ID: 7997616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
    Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.
    Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG
    J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute respiratory distress syndrome after transcatheter arterial chemoembolization of hepatocellular carcinomas.
    Wu GC; Perng WC; Chen CW; Chian CF; Peng CK; Su WL
    Am J Med Sci; 2009 Nov; 338(5):357-60. PubMed ID: 19826242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Survival of 184 patients with hepatocellular carcinoma in cirrhotic liver treated with chemoembolization. A multicenter study].
    Gattoni F; Cornalba G; Brambilla G; Dova S; Pompili G; Rampoldi A; Damiani G; Carnevali G; Uslenghi CM
    Radiol Med; 1998 Apr; 95(4):362-8. PubMed ID: 9676217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
    Wang Y; Chen Y; Ge N; Zhang L; Xie X; Zhang J; Chen R; Wang Y; Zhang B; Xia J; Gan Y; Ren Z; Ye S
    Ann Surg Oncol; 2012 Oct; 19(11):3540-6. PubMed ID: 22532305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization.
    Yang L; Zhang XM; Zhou XP; Tang W; Guan YS; Zhai ZH; Dong GL
    J Vasc Interv Radiol; 2010 Dec; 21(12):1841-6. PubMed ID: 20980165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Warming effect on miriplatin-lipiodol suspension as a chemotherapeutic agent for transarterial chemoembolization for hepatocellular carcinoma: preliminary clinical experience.
    Kora S; Urakawa H; Mitsufuji T; Osame A; Higashihara H; Yoshimitsu K
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1023-9. PubMed ID: 23238851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT.
    Chen R; Geschwind JF; Wang Z; Tacher V; Lin M
    J Vasc Interv Radiol; 2013 Dec; 24(12):1837-44. PubMed ID: 24094672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety margins of hepatocellular carcinoma demonstrated by 3-dimensional fused images of computed tomographic hepatic arteriography/unenhanced computed tomography: prognostic significance in patients who underwent transcatheter arterial chemoembolization.
    Tajima T; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Kakihara D; Honda H
    J Comput Assist Tomogr; 2010; 34(5):712-9. PubMed ID: 20861774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization.
    Miyayama S; Yamashiro M; Hashimoto M; Hashimoto N; Ikuno M; Okumura K; Yoshida M; Matsui O
    J Vasc Interv Radiol; 2013 Apr; 24(4):501-8. PubMed ID: 23452552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of treatment success and short-term effectiveness using C-arm CT immediately after hepatic chemoembolization of HCC.
    Choi WJ; Jeong WK; Kim Y; Kim J; Song SY; Lee S; Kim YH; Park CK
    Hepatogastroenterology; 2014; 61(133):1353-8. PubMed ID: 25436310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of C-arm CT in patients with hepatocellular carcinoma undergoing transhepatic arterial chemoembolization.
    Tognolini A; Louie JD; Hwang GL; Hofmann LV; Sze DY; Kothary N
    J Vasc Interv Radiol; 2010 Mar; 21(3):339-47. PubMed ID: 20133156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visualization of hypervascular liver lesions During TACE: comparison of angiographic C-arm CT and MDCT.
    Meyer BC; Frericks BB; Voges M; Borchert M; Martus P; Justiz J; Wolf KJ; Wacker FK
    AJR Am J Roentgenol; 2008 Apr; 190(4):W263-9. PubMed ID: 18356419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectral CT in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma: A retrospective study.
    Wang J; Shen JL
    Medicine (Baltimore); 2017 Dec; 96(52):e9236. PubMed ID: 29384909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-dimensional evaluation of lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT.
    Wang Z; Lin M; Lesage D; Chen R; Chapiro J; Gu T; Tacher V; Duran R; Geschwind JF
    Acad Radiol; 2014 Mar; 21(3):393-9. PubMed ID: 24507426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
    Chen G; Ma DQ; He W; Zhang BF; Zhao LQ
    World J Gastroenterol; 2008 Oct; 14(37):5738-43. PubMed ID: 18837093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
    Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
    Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result.
    Park YS; Lee CH; Kim JH; Kim IS; Kiefer B; Seo TS; Kim KA; Park CM
    Magn Reson Imaging; 2014 Jul; 32(6):638-46. PubMed ID: 24703575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.